United States · FDA National Drug Code directory
RIFAMPIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67046-1605_410a5d00-f97a-0307-e063-6294a90a9a68
- Product NDC
- 67046-1605
- Form
- CAPSULE
- Composition / generic term
- rifampin
- Labeler
- Coupler LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251013
- Source listing expiry
- 20261231
Source-listed ingredients
- RIFAMPIN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BLISTER PACK (67046-1605-3) · 67046-1605-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →